Cardiovascular Events throughout the Disease Course in Chronic Myeloid Leukaemia Patients Treated with Tyrosine Kinase Inhibitors—A Single-Centre Retrospective Study

Introduction. Cardiovascular risk factors, pre-existing comorbidities, molecular factors, and the direct effects of second- and third-generation BCR-ABL1 tyrosine kinase inhibitors on the vascular endothelium contribute to the progression of cardiovascular (CV) events, especially atherothrombotic co...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Andreea, Tilea, Ioan, Petra, Dorina Nastasia, Tilinca, Mariana-Cornelia, Gliga, Mirela Liana, Demian, Smaranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600382/
https://www.ncbi.nlm.nih.gov/pubmed/33053860
http://dx.doi.org/10.3390/jcm9103269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600382/
https://www.ncbi.nlm.nih.gov/pubmed/33053860
http://dx.doi.org/10.3390/jcm9103269

Ejemplares similares